EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Topical Ivermectin Weekly for 12 Weeks in Pediculosis Capitis

Chinese Journal of Cancer Prevention and Treatment · 17.07.2026 · 33 (7) · 8-13

DOI: 10.61336/cjpt/26-7-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Journal of Cancer Prevention and Treatment, online erschienen am 17.07.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic, heavy infestation with head lice (Pediculus humanus capitis) can rarely cause anaemia, particularly in rural females who already have iron-deficiency anaemia. A single treatment with topical ivermectin (IVM) may produce an earlier response and higher cure rate than oral IVM.

Objective

To determine the efficacy of weekly topical ivermectin (2% concentration) given for 12 weeks in patients with pediculosis capitis.

Methods

This prospective clinical study was conducted in the Department of Dermatology, Abbasi Shaheed Hospital, Karachi, from 17 May to 16 November 2019. A total of 194 patients meeting the inclusion criteria were enrolled by non-probability consecutive sampling. All subjects were treated with 2% topical ivermectin applied to the scalp and hair, left in place for 10 minutes, and rinsed. Infestation and pruritus severity were scored at baseline and at 12 weeks. Efficacy was defined as the absence of live lice at the 12-week assessment. Data were analysed in SPSS v21; results were stratified by age, gender, body mass index (BMI), hair length, hair texture, and hair curliness, with post-stratification chi-square testing (p ≤ 0.05 considered significant).

Results

Of 194 patients, 20.1% were male and 79.9% were female (mean age 27.15 ± 8.78 years). Mean infestation and pruritus scores fell from 1.46 ± 0.74 and 1.65 ± 0.65 at baseline to 0.29 ± 0.52 and 0.31 ± 0.50 at 12 weeks, respectively. At 12 weeks, 73.2% of patients had no infestation and 70.6% had no pruritus. Overall treatment efficacy was 60.3%. Efficacy was significantly associated with male gender (84.6% vs 54.2% in females, p = 0.001) and shorter hair length (≤35 cm: 67.0% vs >35 cm: 53.2%, p = 0.049); no significant association was found with age, BMI, hair texture, or hair curliness.

Conclusion

Weekly topical ivermectin (2%) for 12 weeks demonstrated high efficacy in pediculosis capitis, producing significantly higher cure of infestation and faster relief of pruritus, with male sex and shorter hair length as favourable prognostic factors

Zitieren

APA

(2026). Efficacy of Topical Ivermectin Weekly for 12 Weeks in Pediculosis Capitis. Chinese Journal of Cancer Prevention and Treatment, 33(7), 8-13. https://doi.org/10.61336/cjpt/26-7-2

Vancouver

Efficacy of Topical Ivermectin Weekly for 12 Weeks in Pediculosis Capitis. Chinese Journal of Cancer Prevention and Treatment. 2026;33(7):8-13. doi:10.61336/cjpt/26-7-2

BibTeX
@article{euvimed2026,
  title = {Efficacy of Topical Ivermectin Weekly for 12 Weeks in Pediculosis Capitis},
  journal = {Chinese Journal of Cancer Prevention and Treatment},
  year = {2026},
  volume = {33},
  number = {7},
  pages = {8--13},
  doi = {10.61336/cjpt/26-7-2}
}
Kostenlos starten →